Compare DCM Shriram Fine with Similar Stocks
Stock DNA
Commodity Chemicals
INR 170 Cr (Micro Cap)
9.00
37
0.00%
0.00
0.00%
0.00
Total Returns (Price + Dividend) 
Risk Adjusted Returns v/s 
Returns Beta
News
Announcements 
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
02-Apr-2026 | Source : BSEThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Akshay Dhar
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
02-Apr-2026 | Source : BSEThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Aditi Dhar
Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011
02-Apr-2026 | Source : BSEThe Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Aditi Dhar
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Feb 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 2 Schemes (0.0%)
Held by 37 FIIs (1.49%)
Madhav Bansidhar Shriram (4.94%)
Life Insurance Corporation Of India (4.64%)
24.79%
Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is -0.22% vs 3.81% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is 40.44% vs -223.64% in Sep 2025
Annual Results Snapshot (Consolidated) - Mar'25
Not Applicable: The company has declared_date for only one period
Not Applicable: The company has declared_date for only one period






